FIGURE 2.
Receiver operating characteristic curves of individual or combination of PRL, CEA, and CYFRA21 serum tumor biomarkers in differentiating NSCLC from the healthy controls.
Receiver operating characteristic curves of individual or combination of PRL, CEA, and CYFRA21 serum tumor biomarkers in differentiating NSCLC from the healthy controls.